Barasertib
AZD1152 is the pro-drug of Barasertib, a highly selective Aurora B kinase inhibitor with a cell-free assay IC50 of 0.37 nM. It is widely used in cancer research, demonstrating antitumor activity in both in vitro cellular studies and in vivo xenograft models of leukemia and solid tumors.
Product Specifications
CAS Number
722543-31-9
Product Name Alternative
Leukemia, Inhibitor, inhibit, lung, AuroraKinase, Aurora B, Aurora Kinase, AZD 1152, AZD1152, AZD-1152, Barasertib, Apoptosis, cancer, colon, breast
Field of Research
Cell Biology, Epigenetics & Chromatin
Purity
98.10% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:2 mg/mL (3.4 mM) ; DMSO:33 mg/mL (56.17 mM)
Smiles
CCN (CCCOc1ccc2c (Nc3cc (CC (=O) Nc4cccc (F) c4) [nH]n3) ncnc2c1) CCOP (O) (O) =O
Molecular Formula
C26H31FN7O6P
Molecular Weight
587.54
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Recombinant Bacillus subtilis Uncharacterized protein yycE (yycE)
Recombinant Bacillus subtilis Uncharacterized protein yycE (yycE)
Recombinant Bacillus subtilis Uncharacterized protein yycE (yycE)
Recombinant Bacillus subtilis Uncharacterized protein yycE (yycE)
Recombinant Bacillus subtilis Uncharacterized protein yycE (yycE)